Page 3 - Centric Services News Today

AffaMed Therapeutics has announced dosing of the first subject in the Phase I clinical trial of AM712 to treat retinal diseases in the US.

Kintara Therapeutics has activated the first European site of the VAL-083 treatment arm in the Phase II/III trial for treating glioblastoma.

Apart from pancreatic ductal adenocarcinoma, studies in liver disease, venous leg ulcer, sleep apnoea, and ocular issues are also reviewed.

Humanetics has expanded clinical trial of a new oral drug, BIO 300, for long-haul Covid-19 (long COVID) to include two more US study sites.

Moderna and IAVI are set to commence Phase I IAVI G003 clinical trial of a mRNA HIV vaccine antigen, mRNA-1644, in Rwanda and South Africa.

Imugene and City of Hope have dosed first subject in Phase I trial of a cancer-killing virus, CF33-hNIS (Vaxinia), in solid tumour patients.

Methodology:The clinical trials data used for the analyses were extracted from the Clinical Trials Database of GlobalData’s Pharma Intelligence Center. Clinical Trials are sourced from numerous government, non-government and company clinical trial registries worldwide alongside clinical research publications, scientific conferences, company websites, SEC filings and more. The information is gathered by a combination of automation and secondary research to ensure accuracy and validity. A sma...

Sen-Jam Pharmaceutical has initiated subject enrolment in the Phase II trial of its investigational oral Covid-19 therapy, SJP-002C, in Nepal.

CNS Pharmaceuticals is set to commence its pivotal trial of Berubicin to treat recurrent glioblastoma multiforme (GBM).

Skye Bioscience has retained CMAX clinical Research for Phase I trial of its SBI-100 OE being developed for potential treatment of glaucoma.